Neon Therapeutics Presents Updated Data At The Society For Immunotherapy Of Cancers 33rd Annual Meeting | Latest News RSS feed

Neon Therapeutics Presents Updated Data At The Society For Immunotherapy Of Cancers 33rd Annual Meeting - Latest News


Neon Therapeutics Presents Updated Data at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

Nov. 09, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today presents updated data ... the Society for Imm... read more

Neon Therapeutics Is An Emerging Player In Personalized Immunotherapy With Catalysts Ahead

In the case of Neon, we have a data update for its NT-001 ... Neon will present potentially a broader set of results on NEO-PV-01 at the Society of Immunotherapy of Cancer (SITC) Annual Meeting taking ... read more

Celldex Presents Emerging MerTK Antibody Program at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

Celldex Therapeutics, Inc. (NASDAQ:CLDX) presented data from the Company’s MerTK antibody program in a poster session today at the Society for Immunotherapy of Cancer’s (SITC) 33 rd Annual Meeting. Me... read more

Looking for another news?


Neon Therapeutics to Present at the Society for Immunotherapy of Cancer 33rd Annual Meeting

Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced upcoming presentations at the Society for Immunotherapy of Ca... read more


Cue Biopharma Announces Presentation Highlighting Immuno-STAT Platform and CUE-101 at the 2019 Keystone Symposia Conference

Simcox “Cue Biopharma is pleased to present ... foundational data on CUE-101 and the Immuno-STAT platform at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting in November. read more

More Positives For Roche, The Core Biotech For The Long Run

Biotech and diagnostics company Roche provided several pieces of new or more detailed data over the past month ... with a presentation at the recent American Society of Hematology, or ASH, meeting, ca... read more

Neon Therapeutics Presents Updated Data at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

Nov. 09, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today presents updated data ... Society for ... read more

Celldex Presents Emerging MerTK Antibody Program at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

Celldex Therapeutics, Inc. (CLDX) presented data from the Company’s MerTK antibody program in a poster session today at the Society for Immunotherapy of Cancer's (SITC) 33 rd Annual Meeting. MerTK is ... read more

Neon Therapeutics Presents Updated Data at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

Nov. 09, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today presents updated data ... Society for ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us